Comparison of efficacy between adjuvant chemotherapy and chemoradiation therapy for pancreatic cancer: AJCC stage-based approach

doi:10.5306/wjco.v11.i9.747

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7031)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

309

WORD

282

HTML

2402

Figures (1-3)

296

Tables (1-5)

276

Sum=3565

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

439

Download

942

Sum=1381

Publishing Process of This Article

Item

Count

Browse

718

Download

1367

Sum=2085

Sep 24, 2020 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Oncol. Sep 24, 2020; 11(9): 747-760
Published online Sep 24, 2020. doi: 10.5306/wjco.v11.i9.747

Open in New Tab Full Size Figure Download Figure

Figure 1 Flowchart of patient inclusion. FL: 5-fluorouracil plus leucovorin; PDAC: Pancreatic ductal adenocarcinoma.

Open in New Tab Full Size Figure Download Figure

Figure 2 Kaplan–Meier estimates of overall survival classified by chemoradiation therapy (group A), systemic chemotherapy (group B) and combination therapy with chemoradiation and systemic chemotherapy (group C). A: In patients with American Joint Committee on Cancer stage I/II; B: In patients with American Joint Committee on Cancer stage III. CI: Confidence interval; CRT: Chemoradiation therapy; CRT-SCT: Combination therapy with chemoradiation and systemic chemotherapy; NA: Not available; SCT: Systemic chemotherapy.

Open in New Tab Full Size Figure Download Figure

Figure 3 Kaplan–Meier estimates of recurrence-free survival classified by chemoradiation therapy (group A), systemic chemotherapy (group B) and combination therapy with chemoradiation and systemic chemotherapy (group C). A: In patients with American Joint Committee on Cancer stage I/II; B: In patients with American Joint Committee on Cancer stage III. CI: Confidence interval; CRT: Chemoradiation therapy; CRT-SCT: Combination therapy with chemoradiation and systemic chemotherapy; NA: Not available; SCT: Systemic chemotherapy.

Citation: You MS, Ryu JK, Huh G, Chun JW, Paik WH, Lee SH, Kim YT. Comparison of efficacy between adjuvant chemotherapy and chemoradiation therapy for pancreatic cancer: AJCC stage-based approach. World J Clin Oncol 2020; 11(9): 747-760
URL: https://www.wjgnet.com/2218-4333/full/v11/i9/747.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i9.747